A pilot study of the combination of entinostat with capecitabine in high-risk breast cancer after neoadjuvant therapy. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback